Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (371-380 of 599) with videos related to

Pageof 60
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y<sub>6</sub> receptor antagonistsYoung-Hwan Jung, Qasim Shah, Sarah A Lewicki, et al.
Biochemical Pharmacology|June 21, 2005
Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cellsSusanna Tchilibon, Jian Zhang, Qingfeng Yang, et al.
Nucleic Acids Symposium Series (2004)|December 8, 2006
Synthesis of 3'-ureidoadenosines and their high binding affinity at the mutant A3 adenosine receptorAe Yil Kim, Hea Ok Kim, Myoung Jung Kim, et al.
European Journal of Medicinal Chemistry|January 10, 2021
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibitionZafer Sahin, Sevde Nur Biltekin, Leyla Yurttas, et al.
Drug Development Research|January 18, 2024
Avian and Human Homologues of the P2Y<sub>1</sub> Receptor: Pharmacological, Signaling, and Molecular PropertiesJosé L Boyer, Joel B Schachter, Susan M Sromek, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Structure-Activity Relationship Analysis of 2-Aryl-8-alkynyl Adenine and Nucleoside Scaffolds as A<sub>3</sub> Adenosine Receptor LigandsGibae Kim, Grim Lee, Dnyandev B Jarhad, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2021
Structure-activity relationships of pyrimidine nucleotides containing a 5'-α,β-methylene diphosphonate at the P2Y<sub>6</sub> receptorPaola Oliva, Mirko Scortichini, Clemens Dobelmann, et al.
Journal of Medicinal Chemistry|May 8, 2012
Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutionsDilip K Tosh, Francesca Deflorian, Khai Phan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2011
Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pHKrisztian Kaszas, Jason M Keller, Claudio Coddou, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the 3'-ureido group on binding to the A3 adenosine receptorLak Shin Jeong, Myong Jung Kim, Hea Ok Kim, et al.
Pageof 60

Showing results (371-380 of 599) with videos related to

Sort By:
Pageof 60
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y<sub>6</sub> receptor antagonistsYoung-Hwan Jung, Qasim Shah, Sarah A Lewicki, et al.
Biochemical Pharmacology|June 21, 2005
Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cellsSusanna Tchilibon, Jian Zhang, Qingfeng Yang, et al.
Nucleic Acids Symposium Series (2004)|December 8, 2006
Synthesis of 3'-ureidoadenosines and their high binding affinity at the mutant A3 adenosine receptorAe Yil Kim, Hea Ok Kim, Myoung Jung Kim, et al.
European Journal of Medicinal Chemistry|January 10, 2021
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibitionZafer Sahin, Sevde Nur Biltekin, Leyla Yurttas, et al.
Drug Development Research|January 18, 2024
Avian and Human Homologues of the P2Y<sub>1</sub> Receptor: Pharmacological, Signaling, and Molecular PropertiesJosé L Boyer, Joel B Schachter, Susan M Sromek, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Structure-Activity Relationship Analysis of 2-Aryl-8-alkynyl Adenine and Nucleoside Scaffolds as A<sub>3</sub> Adenosine Receptor LigandsGibae Kim, Grim Lee, Dnyandev B Jarhad, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2021
Structure-activity relationships of pyrimidine nucleotides containing a 5'-α,β-methylene diphosphonate at the P2Y<sub>6</sub> receptorPaola Oliva, Mirko Scortichini, Clemens Dobelmann, et al.
Journal of Medicinal Chemistry|May 8, 2012
Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutionsDilip K Tosh, Francesca Deflorian, Khai Phan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2011
Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pHKrisztian Kaszas, Jason M Keller, Claudio Coddou, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the 3'-ureido group on binding to the A3 adenosine receptorLak Shin Jeong, Myong Jung Kim, Hea Ok Kim, et al.
Pageof 60